Published in Int J Cardiol on November 28, 2008
Persistent comorbid symptoms of depression and anxiety predict mortality in heart disease. Int J Cardiol (2009) 1.70
Association between hyperuricemia and incident heart failure among older adults: a propensity-matched study. Int J Cardiol (2009) 1.38
A functional polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: data from the heart and soul study. PLoS One (2010) 1.25
Systemic and microvascular oxidative stress induced by light chain amyloidosis. Int J Cardiol (2009) 1.13
Biomaterial strategies for alleviation of myocardial infarction. J R Soc Interface (2011) 1.13
Reduced knee extensor function in heart failure is not explained by inactivity. Int J Cardiol (2009) 1.13
Authorship ethics in global health research partnerships between researchers from low or middle income countries and high income countries. BMC Med Ethics (2014) 1.09
Hemostatic markers are associated with the risk and prognosis of atrial fibrillation: the ARIC study. Int J Cardiol (2010) 1.06
Mild hyperkalemia and outcomes in chronic heart failure: a propensity matched study. Int J Cardiol (2009) 1.01
Bureaucrats, researchers, editors, and the impact factor: a vicious circle that is detrimental to science. Clinics (Sao Paulo) (2010) 0.98
320-detector row CT coronary angiography: effects of heart rate and heart rate variability on image quality, diagnostic accuracy and radiation exposure. Br J Radiol (2012) 0.97
Coronary artery disease, coronary revascularization, and outcomes in chronic advanced systolic heart failure. Int J Cardiol (2010) 0.94
Atrial fibrillation and heart failure parallels: lessons for atrial fibrillation prevention. Crit Pathw Cardiol (2011) 0.92
Lipoprotein(a) is strongly associated with coronary artery calcification in type-2 diabetic women. Int J Cardiol (2010) 0.91
Calcium channel regulation in vascular smooth muscle cells: synergistic effects of statins and calcium channel blockers. Int J Cardiol (2009) 0.91
Acidic and basic fibroblast growth factors involved in cardiac angiogenesis following infarction. Int J Cardiol (2010) 0.91
Age, gender, insulin and blood glucose control status alter the risk of ischemic heart disease and stroke among elderly diabetic patients. Cardiovasc Diabetol (2011) 0.91
Transatlantic similarities and differences in major natural history endpoints of heart failure after acute myocardial infarction: a propensity-matched study of the EPHESUS trial. Int J Cardiol (2009) 0.89
LQTS mutation N1325S in cardiac sodium channel gene SCN5A causes cardiomyocyte apoptosis, cardiac fibrosis and contractile dysfunction in mice. Int J Cardiol (2009) 0.89
A systematic review of peer review for scientific manuscripts. Hand (N Y) (2012) 0.88
Dkk1 and Dkk2 regulate epicardial specification during mouse heart development. Int J Cardiol (2010) 0.88
Worsening renal function is not associated with response to treatment in acute heart failure. Int J Cardiol (2012) 0.87
Oxidative stress and systemic inflammation as modifiers of cardiac autonomic responses to particulate air pollution. Int J Cardiol (2014) 0.87
Evaluation of CT coronary artery angiography with 320-row detector CT in a high-risk population. Br J Radiol (2011) 0.86
Differentiation induction of mouse embryonic stem cells into sinus node-like cells by suramin. Int J Cardiol (2009) 0.85
Opposing cardiac effects of autoantibody activation of β-adrenergic and M2 muscarinic receptors in cardiac-related diseases. Int J Cardiol (2010) 0.85
Gender-related dissociation in outcomes in chronic heart failure: reduced mortality but similar hospitalization in women. Int J Cardiol (2009) 0.85
13q13.1-q13.2 deletion in tetralogy of Fallot: clinical report and a literature review. Int J Cardiol (2010) 0.84
Epidemiology of stroke in chronic heart failure patients with normal sinus rhythm: findings from the DIG stroke sub-study. Int J Cardiol (2009) 0.84
Instantly Converting Atrial Fibrillation into Sinus Rhythm by a Digital Rectal Exam on a 29-year-Old Male. Clin Med Insights Case Rep (2010) 0.84
Surveillance of cardiovascular risk in the normotensive patient with repaired aortic coarctation. Int J Cardiol (2008) 0.83
Direct inhibitory effects of Ganciclovir on ICAM-1 expression and proliferation in human coronary vascular cells (SI/MPL-ratio: >1). Med Sci Monit (2011) 0.83
Left atrial volume and index by multi-detector computed tomography: comprehensive analysis from predictors of enlargement to predictive value for acute coronary syndrome (ROMICAT study). Int J Cardiol (2009) 0.83
Tissue inhibitor of metalloproteinase-2 gene delivery ameliorates postinfarction cardiac remodeling. Clin Transl Sci (2011) 0.82
The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusion. Int J Cardiol (2009) 0.82
Evaluation of in-stent restenosis in the APPROACH trial (Assessment on the Prevention of Progression by Rosiglitazone On Atherosclerosis in diabetes patients with Cardiovascular History). Int J Cardiovasc Imaging (2011) 0.82
A new automated system to identify a consistent sampling position to make tissue Doppler and transmitral Doppler measurements of E, E' and E/E'. Int J Cardiol (2010) 0.81
The temporal and spatial expression patterns of ABCG2 in the developing human heart. Int J Cardiol (2010) 0.81
Outcomes in younger and older adults with chronic advanced systolic heart failure: a propensity-matched study. Int J Cardiol (2010) 0.81
Morphological and functional evaluation of the bioresorption of the bioresorbable everolimus-eluting vascular scaffold using IVUS, echogenicity and vasomotion testing at two year follow-up: a patient level insight into the ABSORB A clinical trial. Int J Cardiovasc Imaging (2011) 0.81
Estimate of the abundance of cardiomyopathic mutations in the β-myosin gene. Int J Cardiol (2009) 0.81
The utility of cardiopulmonary exercise testing in the assessment of suspected microvascular ischemia. Int J Cardiol (2009) 0.80
Association of obesity and biomarkers of inflammation and endothelial dysfunction in adults in Inner Mongolia, China. Int J Cardiol (2010) 0.80
Occlusion of Fontan fenestrations using Amplatzer septal occluder. Int J Cardiovasc Imaging (2010) 0.79
Caveolin and β1-integrin coordinate angiotensinogen expression in cardiac myocytes. Int J Cardiol (2012) 0.78
Inflammatory rebound phenomenon after abrupt withdrawal of statin is a mature point of view but not hypotheses. Int J Cardiol (2011) 0.77
Risk and fate of residual interatrial shunting after transcatheter closure of patent foramen ovale: a long term follow up study. Eur J Med Res (2011) 0.77
PARP inhibition in atherosclerosis and its effects on dendritic cells, T cells and auto-antibody levels. Eur J Med Res (2011) 0.76
Exposure to tricyclic antidepressants is associated with an increased risk of incident CHD events in a population-based study. Int J Cardiol (2009) 0.76
Utility of transthoracic echocardiography to estimate severity of right ventricular dysfunction: an MRI comparison study. Int J Cardiovasc Imaging (2011) 0.76
Relation of uric acid levels to aortic root dilatation in hypertensive patients with and without metabolic syndrome. J Zhejiang Univ Sci B (2010) 0.75
A case of type I variant Kounis syndrome with Samter-Beer triad. World J Cardiol (2013) 0.75
Stenting for left main coronary artery occlusion in adolescent: A case report. World J Cardiol (2010) 0.75
Prevalence of suspected hypertrophic cardiomyopathy or left ventricular hypertrophy based on race and gender in teenagers using screening echocardiography. Cardiovasc Ultrasound (2010) 0.75
Best practices for allocating appropriate credit and responsibility to authors of multi-authored articles. Front Psychol (2011) 0.75
Flat-panel versus 64-channel computed tomography for in vivo quantitative characterization of aortic atherosclerotic plaques. Int J Cardiol (2010) 0.75
The importance of considering alternative or combination strategies for lowering LDL-C. Int J Cardiol (2009) 0.75
Isolated dextrocardia and congenital heart blocking. Radiol Case Rep (2015) 0.75
Evolution in the management of acute myocardial infarction in the autonomous community of valencia (Spain): ten years of the primvac registry (1995-2004). Int J Biomed Sci (2010) 0.75
Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data. Int J Cardiol (2010) 0.75
Dietary inflammatory potential is linked to cardiovascular disease risk burden in the US adult population. Int J Cardiol (2017) 0.75
Necessary but not sufficient: unique author identifiers. BMJ Innov (2016) 0.75
Increased metaboreceptor stimulation explains the exaggerated exercise pressor reflex seen in heart failure. J Appl Physiol (1985) (2007) 4.02
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J (2005) 3.89
Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation (2003) 3.89
Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation (2002) 3.34
Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by non-linear analysis: oxygen uptake efficiency slope. Eur Heart J (2005) 2.84
Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation (2002) 2.71
Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle. J Cachexia Sarcopenia Muscle (2010) 2.49
Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study. J Am Coll Cardiol (2004) 2.29
Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. J Am Coll Cardiol (2005) 2.28
Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). J Am Coll Cardiol (2009) 2.20
The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol (2003) 2.12
Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial. J Am Coll Cardiol (2012) 2.11
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet (2003) 2.10
Top of the charts: download versus citations in the International Journal of Cardiology. Int J Cardiol (2005) 2.06
Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol (2007) 1.92
Statement on authorship and publishing ethics in the International Journal of Cardiology. Int J Cardiol (2011) 1.90
How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH. Int J Cardiol (2002) 1.83
Contemporary (post-Wills) survey of the views of Australian medical researchers: importance of funding, infrastructure and motivators for a research career. Med J Aust (2005) 1.79
Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study. JAMA (2003) 1.64
Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Circulation (2004) 1.59
Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation (2002) 1.58
Retracted Nonsurgical reduction of the interventricular septum in patients with hypertrophic cardiomyopathy. N Engl J Med (2002) 1.56
Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail (2003) 1.54
Omapatrilat--the story of Overture and Octave. Int J Cardiol (2002) 1.49
The Research Quality Framework and its implications for health and medical research: time to take stock? Med J Aust (2006) 1.49
Advances in the non-drug, non-surgical, non-device management of chronic heart failure. Int J Cardiol (2005) 1.45
Patient descriptions of breathlessness in heart failure. Int J Cardiol (2005) 1.42
Retraction: Shamim et Al. Nonsurgical reduction of the interventricular septum in patients with hypertrophic cardiomyopathy. N Engl J Med 2002;347:1326-33. N Engl J Med (2003) 1.40
Exercise training for systolic heart failure: Cochrane systematic review and meta-analysis. Eur J Heart Fail (2010) 1.34
Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure. J Am Coll Cardiol (2002) 1.31
Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure? Int J Cardiol (2002) 1.28
Exercise-based rehabilitation for heart failure. Cochrane Database Syst Rev (2014) 1.28
Muscle metaboreflex-induced increases in stroke volume. Med Sci Sports Exerc (2003) 1.18
Oscillatory ventilation during exercise in patients with chronic heart failure: clinical correlates and prognostic implications. Chest (2002) 1.16
Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial. Eur Heart J (2004) 1.13
Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease. Am J Cardiol (2003) 1.12
Heat shock protein 70 in patients with chronic heart failure: relation to disease severity and survival. Int J Cardiol (2004) 1.11
Muscle wasting disease: a proposal for a new disease classification. J Cachexia Sarcopenia Muscle (2014) 1.10
The regulation and measurement of plasma volume in heart failure. J Am Coll Cardiol (2002) 1.09
Albumin levels predict survival in patients with heart failure and preserved ejection fraction. Eur J Heart Fail (2011) 1.07
Congenital heart disease: the original heart failure syndrome. Eur Heart J (2003) 1.07
Prevention of liver cancer cachexia-induced cardiac wasting and heart failure. Eur Heart J (2013) 1.06
A qualitative study of chronic heart failure patients' understanding of their symptoms and drug therapy. Eur J Heart Fail (2002) 1.02
Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis. J Med Virol (2004) 1.00
NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudy. Eur J Heart Fail (2004) 0.98
Chemical mediators of the muscle ergoreflex in chronic heart failure: a putative role for prostaglandins in reflex ventilatory control. Circulation (2002) 0.98
Effect of interleukin-10 on the production of tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with chronic heart failure. Am J Cardiol (2002) 0.97
Relationship between detrended fluctuation analysis and spectral analysis of heart-rate variability. Physiol Meas (2002) 0.96
Global impairment of cardiac autonomic nervous activity late after repair of tetralogy of Fallot. Circulation (2002) 0.95
Diuretics for heart failure. Cochrane Database Syst Rev (2012) 0.95
Exercise training in chronic heart failure: effects on pro-inflammatory markers. Eur J Heart Fail (2005) 0.95
Skeletal muscle reflex in heart failure patients: role of hydrogen. Circulation (2003) 0.94
Sleep-disordered breathing in a general heart failure population: relationships to neurohumoral activation and subjective symptoms. J Sleep Res (2006) 0.93
Obesity paradox as a component of reverse epidemiology in heart failure. Arch Intern Med (2005) 0.93
Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure. Am J Cardiol (2002) 0.92
Differential contribution of dead space ventilation and low arterial pCO2 to exercise hyperpnea in patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol (2004) 0.92
Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a beta-blocker). Int J Cardiol (2004) 0.92
Impact of periodic breathing on measurement of oxygen uptake and respiratory exchange ratio during cardiopulmonary exercise testing. Clin Sci (Lond) (2002) 0.92
Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration. Int J Cardiol (2002) 0.91
Global impairment of cardiac autonomic nervous activity late after the Fontan operation. Circulation (2003) 0.91
Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients. Int J Cardiol (2006) 0.90
Prediction of mortality in chronic heart failure from peak oxygen consumption adjusted for either body weight or lean tissue. J Card Fail (2004) 0.90
Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha. Int J Cardiol (2002) 0.88
The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats. J Cachexia Sarcopenia Muscle (2013) 0.87
Anaemia among patients with heart failure and preserved or reduced ejection fraction: results from the SENIORS study. Eur J Heart Fail (2011) 0.87
Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition. Int J Cardiol (2008) 0.86
The epidemiological enigma of heart failure with preserved systolic function. Eur J Heart Fail (2004) 0.86
Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation: insights from SENIORS. Eur J Heart Fail (2012) 0.86
Echocardiography-derived variables predict outcome in patients with nonischemic dilated cardiomyopathy with or without a restrictive filling pattern. Am Heart J (2002) 0.86
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. Rev Esp Cardiol (Engl Ed) (2016) 0.85
The epidemiology of heart failure in Australia. Int J Cardiol (2006) 0.85
Rationale for use of an exercise end point and design for the ADVANCE (A Dose evaluation of a Vasopressin ANtagonist in CHF patients undergoing Exercise) trial. Am Heart J (2003) 0.85
The relationship between age and production of tumour necrosis factor-alpha in healthy volunteers and patients with chronic heart failure. Int J Cardiol (2003) 0.85
Adherence to ethical standards in publishing scientific articles: a statement from the International Journal of Cardiology. Int J Cardiol (2012) 0.85
Whole blood endotoxin responsiveness in patients with chronic heart failure: the importance of serum lipoproteins. Eur J Heart Fail (2005) 0.84
The E-selectin SER128ARG gene polymorphism and restenosis after successful coronary angioplasty. Int J Cardiol (2002) 0.84
Haemoglobin concentration and prognosis in new cases of heart failure. Lancet (2003) 0.84
The anti-CD14 antibody IC14 suppresses ex vivo endotoxin stimulated tumor necrosis factor-alpha in patients with chronic heart failure. Eur J Heart Fail (2005) 0.84
Beta-blocker therapy for dynamic left-ventricular outflow tract obstruction. Int J Cardiol (2002) 0.83
Putative contribution of prostaglandin and bradykinin to muscle reflex hyperactivity in patients on Ace-inhibitor therapy for chronic heart failure. Eur Heart J (2004) 0.83
Heart transplantation in heart failure: the prognostic importance of body mass index at time of surgery and subsequent weight changes. Eur J Heart Fail (2007) 0.83
Relationship of skeletal muscle metaboreceptors in the upper and lower limbs with the respiratory control in patients with heart failure. Clin Sci (Lond) (2002) 0.83
Effect of anemia on exercise tolerance in chronic heart failure in men. Am J Cardiol (2003) 0.82
Wasting of the left ventricle in patients with cardiac cachexia: a cardiovascular magnetic resonance study. Int J Cardiol (2004) 0.81
Is central nervous system processing altered in patients with heart failure? Eur Heart J (2004) 0.81
Home-based exercise training modulates pro-oxidant substrates in patients with chronic heart failure. Eur J Heart Fail (2005) 0.81
Why ventilatory inefficiency matters in chronic heart failure. Eur Heart J (2005) 0.81
Abnormal temporal dynamics of blood pressure and RR interval regulation in patients with chronic heart failure: relationship to baroreflex sensitivity. Int J Cardiol (2002) 0.80
Reduced confounding by impaired ventilatory function with oxygen uptake efficiency slope and VE/VCO2 slope rather than peak oxygen consumption to assess exercise physiology in suspected heart failure. Congest Heart Fail (2010) 0.80
Influence of valve prosthesis type on the recovery of ventricular dysfunction and subendocardial ischaemia following valve replacement for aortic stenosis. Int J Cardiol (2004) 0.79
Carvedilol reduces the costs of medical care in severe heart failure: an economic analysis of the COPERNICUS study applied to the United Kingdom. Int J Cardiol (2005) 0.79
Reproducibility of the measurement of the muscle ergoreflex activity in chronic heart failure. Eur J Heart Fail (2003) 0.79
Variability of phase shift between blood pressure and heart rate fluctuations: a marker of short-term circulation control. Circulation (2003) 0.78
Exercise hyperventilation in chronic heart failure is not caused by systemic lactic acidosis. Eur J Heart Fail (2005) 0.78
Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS). Rationale and design. Int J Cardiol (2002) 0.78
MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials? Int J Cardiol (2002) 0.78
The cardiac component of cardiac cachexia. Am Heart J (2002) 0.78